Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Russell viper venom"'
Autor:
Armando Tripodi
Publikováno v:
Biomedicines, Vol 9, Iss 7, p 844 (2021)
Lupus anticoagulant (LA) is one of the three laboratory parameters (the others being antibodies to either cardiolipin or β2-glycoprotein I) which defines the rare but potentially devastating condition known as antiphospholipid syndrome (APS). Testin
Externí odkaz:
https://doaj.org/article/bdf8b4fda10146c1ada946b4771b98b7
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 10, Pp EC08-EC11 (2018)
Introduction: Recurrent miscarriage is the occurrence of three or more consecutive pregnancy loss before 20 weeks of gestation. Antiphospholipid Antibodies (APAs) are one of the causes responsible for recurrent pregnancy loss. Aim: Estimation of APAs
Externí odkaz:
https://doaj.org/article/3fc13af9a0c44d6c857caff2fdf16022
Publikováno v:
JAAD Case Reports
JAAD Case Reports, Vol 16, Iss, Pp 50-52 (2021)
JAAD Case Reports, Vol 16, Iss, Pp 50-52 (2021)
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by potentially life-threatening recurrent vascular thrombosis, miscarriage, and the presence of antiphospholipid antibodies, including anti-cardiolipin, anti-beta 2 glycop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb949a1b852c33ad152889fa808e230a
http://europepmc.org/articles/PMC8426164
http://europepmc.org/articles/PMC8426164
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Toxicon. 172:15-18
Despite continued destruction of human lives by snakebites, appreciable improvements in immunotherapies have not been made. We selected and characterized venom-specific single domain antibodies (sdAbs) from a constructed phage display library of came
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4ac1c9aed15967db8cf7d7e0b330d39
https://doi.org/10.1016/j.toxicon.2019.10.240
https://doi.org/10.1016/j.toxicon.2019.10.240
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S. Subramanian, A. Siegemund, Pierre Suchon, Elaine Gray, Michela Cini, Veena Chantarangkul, Marta Martinuzzo, Sophie Testa, Cristina Legnani, Katrien Devreese, J. S Dlott, Paola Pradella, Roberta Giacomello, Armando Tripodi
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2017, 15 (6), pp.1180-1190. ⟨10.1111/jth.13678⟩
Journal of Thrombosis and Haemostasis, Wiley, 2017, 15 (6), pp.1180-1190. ⟨10.1111/jth.13678⟩
Essentials Between-lab variations of cut-off values in lupus anticoagulant detection are unknown. Cut-off values were calculated in 11 labs each testing plasma from 120 donors with 3 platforms. Major variation was observed even within the same platfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54348fc69ce6681e7dd7180ff06c2e03
https://doi.org/10.1111/jth.13678
https://doi.org/10.1111/jth.13678
Autor:
Tiong Lee Len, Ning, Shirley Tan Siang, Saiful Shakirin Rosli, Wei, Choo Chee, Tiong Wen Ni, Siang, Yeo Leh, Jawing Chunggat, Yip, Alan Fong Yean
IntroductionEcarin clotting assay (ECA) and Russell Viper Venom Assay (RVV) are established to assess coagulation effects of Factor II inhibitor i.e. Dabigatran and Factor Xa inhibitors i.e. Rivaroxaban and Apixaban; respectively. These assays can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c22797fee38536d47c415be6d2a0f8
Autor:
Kyung-Hee Kim, Ja Young Seo, Woo-Jae Kwoun, Pil Whan Park, Soon Ho Park, Jeong Yeal Ahn, Hwan Tae Lee, Yiel-Hea Seo
Publikováno v:
Journal of Clinical Laboratory Analysis
Background Apixaban and rivaroxaban are approved for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and embolic stroke in atrial fibrillation (AF) patients. The aim of this study was to find appropriate methods o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fc50166d4cb418aa4f98651cdca74e3
https://doi.org/10.1002/jcla.22869
https://doi.org/10.1002/jcla.22869
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 10, Pp EC08-EC11 (2018)
Introduction: Recurrent miscarriage is the occurrence of three or more consecutive pregnancy loss before 20 weeks of gestation. Antiphospholipid Antibodies (APAs) are one of the causes responsible for recurrent pregnancy loss. Aim: Estimation of APAs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a78bedcd3192dd1c9a8fd2d13246dd